Article Information
History
- Received July 12, 2021
- Revision received September 24, 2021
- Accepted October 25, 2021
- Published online January 13, 2022.
Copyright & Usage
© 2022 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Ryo Ochi, BA,
- Eric Plitman, PhD,
- Raihaan Patel, BASc,
- Ryosuke Tarumi, MD, PhD,
- Yusuke Iwata, MD, PhD,
- Sakiko Tsugawa, MD,
- Julia Kim, MSc,
- Shiori Honda, MA,
- Yoshihiro Noda, MD, PhD,
- Hiroyuki Uchida, MD, PhD,
- Gabriel A. Devenyi, PhD,
- Masaru Mimura, MD, PhD,
- Ariel Graff-Guerrero, MD, PhD*,
- M. Mallar Chakravarty, PhD*,
- Shinichiro Nakajima, MD, PhD*
- From the Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan (Ochi, Tarumi, Tsugawa, Honda, Noda, Uchida, Mimura, Nakajima); the Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Que., Canada (Plitman, Patel, Devenyi, Chakravarty); the Department of Psychiatry, McGill University, Montreal, Que., Canada (Plitman, Devenyi, Chakravarty); the Department of Biological and Biomedical Engineering, McGill University, Montreal, Que., Canada (Patel, Chakravarty); the Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont., Canada (Iwata, Kim, Graff-Guerrero, Nakajima); and the Institute of Medical Science, University of Toronto, Toronto, Ont., Canada (Kim, Graff-Guerrero)
- Correspondence to: S. Nakajima, Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan, 160-8582; shinichiro_nakajima{at}hotmail.com